MedTrace Logo

Comparison of Two Devices Using Near-infra Red Spectroscopy During a Vascular Occlusion Test

NCT01848977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-01-26

Study results available
· View outcomes & findings →

Summary

Tissue oxygen saturation is non-invasively measured using near-infrared spectroscopy, by two device, INVOS®(somanetics Corporation, USA ) and InSpectra™ (Hutchinson Technology, USA). Each probes are attached to both thenar muscles and vascular occlusion test (VOT) is performed. The investigators will compare the Invos® data to InSpectra™ to investigate whether tissue oxygen saturation values by INVOS® can substitute for InSpectra™.

Conditions

  • Healthy

Interventions

DEVICE

vascular occlusion test

Using Invos® probe attacted to one thenar muscle, tissue oxgyenation is measured by VOT.

DEVICE

vascular occlusion test

Using Inspectra™ probe attacted to another thenar muscle, tissue oxgyenation is measured by VOT.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jin-Tae Kim, Ph.D. · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
26 Years
Max Age
41 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01848977 on ClinicalTrials.gov